vabicaserin

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer

Conditions

Healthy SubjectsSchizophrenia

Phase 1

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

CompletedNCT00541996

Wyeth is now a wholly owned subsidiary of PfizerSchizophrenia

Start: 2007-08-31End: 2007-10-31Updated: 2007-12-05

Comparative Formulation Study of Vabicaserin

CompletedNCT00928551

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2009-06-30End: 2009-09-30Target: 15Updated: 2009-09-11

Phase 2

Study Evaluating Vabicaserin in Subjects With Schizophrenia

CompletedNCT00563706

PfizerSchizophrenia

Start: 2007-12-31End: 2008-06-30Updated: 2014-03-20